DISC MEDICINE INC (IRON) Fundamental Analysis & Valuation
NASDAQ:IRON • US2546041011
Current stock price
66.32 USD
-0.98 (-1.46%)
At close:
66.32 USD
0 (0%)
After Hours:
This IRON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IRON Profitability Analysis
1.1 Basic Checks
- In the past year IRON has reported negative net income.
- In the past year IRON has reported a negative cash flow from operations.
- In the past 5 years IRON always reported negative net income.
- IRON had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- IRON has a better Return On Assets (-26.30%) than 69.83% of its industry peers.
- IRON's Return On Equity of -28.68% is fine compared to the rest of the industry. IRON outperforms 76.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.3% | ||
| ROE | -28.68% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- IRON does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. IRON Health Analysis
2.1 Basic Checks
- There is no outstanding debt for IRON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 22.27 indicates that IRON is not in any danger for bankruptcy at the moment.
- IRON has a better Altman-Z score (22.27) than 88.59% of its industry peers.
- A Debt/Equity ratio of 0.04 indicates that IRON is not too dependend on debt financing.
- IRON has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: IRON outperforms 42.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 22.27 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- IRON has a Current Ratio of 21.94. This indicates that IRON is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of IRON (21.94) is better than 95.74% of its industry peers.
- A Quick Ratio of 21.94 indicates that IRON has no problem at all paying its short term obligations.
- IRON has a better Quick ratio (21.94) than 95.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 21.94 | ||
| Quick Ratio | 21.94 |
3. IRON Growth Analysis
3.1 Past
- IRON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.63%.
EPS 1Y (TTM)-50.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- IRON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.91% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-20.54%
EPS Next 2Y-12.97%
EPS Next 3Y0.96%
EPS Next 5Y17.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. IRON Valuation Analysis
4.1 Price/Earnings Ratio
- IRON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRON. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.97%
EPS Next 3Y0.96%
5. IRON Dividend Analysis
5.1 Amount
- No dividends for IRON!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IRON Fundamentals: All Metrics, Ratios and Statistics
66.32
-0.98 (-1.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26 2026-02-26/bmo
Earnings (Next)05-05 2026-05-05
Inst Owners96.15%
Inst Owner Change0%
Ins Owners0.68%
Ins Owner Change-10.96%
Market Cap2.53B
Revenue(TTM)N/A
Net Income(TTM)-212.18M
Analysts86.32
Price Target102.17 (54.06%)
Short Float %14.08%
Short Ratio6.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.37%
Min EPS beat(2)-18.57%
Max EPS beat(2)7.82%
EPS beat(4)2
Avg EPS beat(4)-8.16%
Min EPS beat(4)-33.61%
Max EPS beat(4)11.71%
EPS beat(8)5
Avg EPS beat(8)-0.06%
EPS beat(12)7
Avg EPS beat(12)-3.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.36%
PT rev (3m)-15.77%
EPS NQ rev (1m)-0.89%
EPS NQ rev (3m)2.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.99%
Revenue NQ rev (1m)-100%
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)-47.44%
Revenue NY rev (3m)-82.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.42 | ||
| P/tB | 3.42 | ||
| EV/EBITDA | N/A |
EPS(TTM)-6.01
EYN/A
EPS(NY)-7.24
Fwd EYN/A
FCF(TTM)-4.75
FCFYN/A
OCF(TTM)-4.73
OCFYN/A
SpS0
BVpS19.39
TBVpS19.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.3% | ||
| ROE | -28.68% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 332.03% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 21.94 | ||
| Quick Ratio | 21.94 | ||
| Altman-Z | 22.27 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)248.25%
Cap/Depr(5y)188.37%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.35%
EPS Next Y-20.54%
EPS Next 2Y-12.97%
EPS Next 3Y0.96%
EPS Next 5Y17.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-17.86%
EBIT Next 3Y-10.68%
EBIT Next 5YN/A
FCF growth 1Y-92.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.06%
OCF growth 3YN/A
OCF growth 5YN/A
DISC MEDICINE INC / IRON Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for DISC MEDICINE INC?
ChartMill assigns a fundamental rating of 2 / 10 to IRON.
What is the valuation status of DISC MEDICINE INC (IRON) stock?
ChartMill assigns a valuation rating of 0 / 10 to DISC MEDICINE INC (IRON). This can be considered as Overvalued.
How profitable is DISC MEDICINE INC (IRON) stock?
DISC MEDICINE INC (IRON) has a profitability rating of 1 / 10.
What is the earnings growth outlook for DISC MEDICINE INC?
The Earnings per Share (EPS) of DISC MEDICINE INC (IRON) is expected to decline by -20.54% in the next year.